Cargando…
The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model
PURPOSE: The aim of this study was to investigate and compare the effects of udenafil and mannitol in an experimental renal ischemia-reperfusion (I/R) injury model. MATERIALS AND METHODS: A total of 64 female Wister Albino rats were used. Right nephrectomy was performed in all groups. In the control...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Urological Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494354/ https://www.ncbi.nlm.nih.gov/pubmed/28681040 http://dx.doi.org/10.4111/icu.2017.58.4.289 |
_version_ | 1783247664726409216 |
---|---|
author | Özlülerden, Yusuf Toktaş, Cihan Aybek, Hülya Küçükatay, Vural Şen Türk, Nilay Zumrutbas, Ali Ersin |
author_facet | Özlülerden, Yusuf Toktaş, Cihan Aybek, Hülya Küçükatay, Vural Şen Türk, Nilay Zumrutbas, Ali Ersin |
author_sort | Özlülerden, Yusuf |
collection | PubMed |
description | PURPOSE: The aim of this study was to investigate and compare the effects of udenafil and mannitol in an experimental renal ischemia-reperfusion (I/R) injury model. MATERIALS AND METHODS: A total of 64 female Wister Albino rats were used. Right nephrectomy was performed in all groups. In the control group; I/R injury was not performed. In the I/R group; left renal pedicle was clamped for 45 minutes and then underwent 60 minutes and 24 hours of reperfusion. In the mannitol group; 1 mL 20% mannitol was given intravenously 15 minutes before clamping. In the udenafil group; 10-mg/kg udenafil was given orally 1 hour before clamping. Creatinine (Cr), blood urea nitrogen (BUN), Cr clearance, malondialdehyde, neutrophil gelatinase associated lipocalin (NGAL), histological examination and DNA damage (Comet Assay method) levels were compared in tissue, serum and urine samples. RESULTS: Udenafil had a better protective effect than mannitol according to biochemical parameters (Cr, BUN, Cr clearance, and NGAL levels) and histopathological findings when compared with the I/R group. In the Comet sampling analysis no significant difference was detected. CONCLUSIONS: Udenafil has a better renoprotective effect than mannitol against I/R injury and this effect supports more functional improvements. Further clinical trials are needed to demonstrate those effects and clinical utility of udenafil for that purpose in humans. |
format | Online Article Text |
id | pubmed-5494354 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | The Korean Urological Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-54943542017-07-05 The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model Özlülerden, Yusuf Toktaş, Cihan Aybek, Hülya Küçükatay, Vural Şen Türk, Nilay Zumrutbas, Ali Ersin Investig Clin Urol Original Article PURPOSE: The aim of this study was to investigate and compare the effects of udenafil and mannitol in an experimental renal ischemia-reperfusion (I/R) injury model. MATERIALS AND METHODS: A total of 64 female Wister Albino rats were used. Right nephrectomy was performed in all groups. In the control group; I/R injury was not performed. In the I/R group; left renal pedicle was clamped for 45 minutes and then underwent 60 minutes and 24 hours of reperfusion. In the mannitol group; 1 mL 20% mannitol was given intravenously 15 minutes before clamping. In the udenafil group; 10-mg/kg udenafil was given orally 1 hour before clamping. Creatinine (Cr), blood urea nitrogen (BUN), Cr clearance, malondialdehyde, neutrophil gelatinase associated lipocalin (NGAL), histological examination and DNA damage (Comet Assay method) levels were compared in tissue, serum and urine samples. RESULTS: Udenafil had a better protective effect than mannitol according to biochemical parameters (Cr, BUN, Cr clearance, and NGAL levels) and histopathological findings when compared with the I/R group. In the Comet sampling analysis no significant difference was detected. CONCLUSIONS: Udenafil has a better renoprotective effect than mannitol against I/R injury and this effect supports more functional improvements. Further clinical trials are needed to demonstrate those effects and clinical utility of udenafil for that purpose in humans. The Korean Urological Association 2017-07 2017-06-27 /pmc/articles/PMC5494354/ /pubmed/28681040 http://dx.doi.org/10.4111/icu.2017.58.4.289 Text en © The Korean Urological Association, 2017 http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Özlülerden, Yusuf Toktaş, Cihan Aybek, Hülya Küçükatay, Vural Şen Türk, Nilay Zumrutbas, Ali Ersin The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model |
title | The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model |
title_full | The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model |
title_fullStr | The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model |
title_full_unstemmed | The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model |
title_short | The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model |
title_sort | renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494354/ https://www.ncbi.nlm.nih.gov/pubmed/28681040 http://dx.doi.org/10.4111/icu.2017.58.4.289 |
work_keys_str_mv | AT ozlulerdenyusuf therenoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel AT toktascihan therenoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel AT aybekhulya therenoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel AT kucukatayvural therenoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel AT senturknilay therenoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel AT zumrutbasaliersin therenoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel AT ozlulerdenyusuf renoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel AT toktascihan renoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel AT aybekhulya renoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel AT kucukatayvural renoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel AT senturknilay renoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel AT zumrutbasaliersin renoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel |